• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Preventing and treating hepatitis B infection.预防和治疗乙型肝炎感染。
BMJ. 2004 Nov 6;329(7474):1080-6. doi: 10.1136/bmj.329.7474.1080.
2
Hepatitis B immunization after liver transplantation: what is the answer?
Liver Transpl. 2005 Oct;11(10):1181-3. doi: 10.1002/lt.20538.
3
Posttransplantation: future therapies.移植后：未来的治疗方法。
Semin Liver Dis. 2000;20 Suppl 1:19-24.
4
[Can the recurrence of hepatitis B after liver transplantation be prevented?].[肝移植后乙肝复发能否预防？]
Gastroenterol Hepatol. 1996 Dec;19(10):521-3.
5
[Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].[乙型肝炎病毒（HBV）感染的预防、诊断与治疗：指南更新，德国医学专业协会注册编号021/011]
Z Gastroenterol. 2007 Jun;45(6):525-74. doi: 10.1055/s-2007-963232. Epub 2007 Jun 6.
6
Hepatitis B in liver transplant recipients as a special model of antiviral drug development.肝移植受者中的乙型肝炎作为抗病毒药物研发的特殊模型。
Methods Mol Med. 2004;96:319-41. doi: 10.1385/1-59259-670-3:319.
7
Achieving ultimate control of hepatitis B infection in China: progress and challenges.在中国实现对乙型肝炎感染的最终控制：进展与挑战。
J Viral Hepat. 2010 Mar;17 Suppl 1:2-3. doi: 10.1111/j.1365-2893.2010.01265.x.
8
Prophylaxis and treatment of recurrent hepatitis B after liver transplantation.肝移植后复发性乙型肝炎的预防和治疗。
Transplantation. 2003 Feb 15;75(3 Suppl):S41-4. doi: 10.1097/01.TP.0000047027.68167.07.
9
Hepatitis B vaccines: protective efficacy and therapeutic potential.乙肝疫苗：保护效力与治疗潜力
Pathol Biol (Paris). 2010 Aug;58(4):288-95. doi: 10.1016/j.patbio.2010.01.006. Epub 2010 Apr 10.
10
Chemotherapy for hepatitis B: new treatment options necessitate reappraisal of traditional endpoints.
Gastroenterology. 2002 Dec;123(6):2135-40. doi: 10.1053/gast.2002.37288.

引用本文的文献

1
Acetaldehyde suppresses HBV-MHC class I complex presentation on hepatocytes via induction of ER stress and Golgi fragmentation.乙醛通过诱导内质网应激和高尔基体碎片化来抑制肝细胞上的 HBV-MHC Ⅰ类复合物的呈递。
Am J Physiol Gastrointest Liver Physiol. 2020 Oct 1;319(4):G432-G442. doi: 10.1152/ajpgi.00109.2020. Epub 2020 Aug 5.
2
Comparative effectiveness of anti-viral drugs with dual activity for treating hepatitis B and HIV co-infected patients: a network meta-analysis.抗乙肝和 HIV 共感染患者的具有双重活性的抗病毒药物的疗效比较：一项网络荟萃分析。
BMC Infect Dis. 2018 Nov 14;18(1):564. doi: 10.1186/s12879-018-3506-x.
3
Hepatitis B Infection: What The Primary Care Doctors Should Know.乙型肝炎感染：基层医疗医生应了解的内容。
Malays Fam Physician. 2006 Apr 30;1(1):8-10. eCollection 2006.
4
Interpreting hepatitis B serology.解读乙肝血清学检查结果
Malays Fam Physician. 2007 Apr 30;2(1):31-2. eCollection 2007.
5
Factors associated with alcohol consumption in hepatitis B carriers: a nationwide study in the Republic of Korea.乙肝携带者饮酒相关因素：韩国全国性研究
PLoS One. 2014 Nov 11;9(11):e110144. doi: 10.1371/journal.pone.0110144. eCollection 2014.
6
Knowledge, attitudes and practice of primary health care physicians towards hepatitis B virus in Al-Jouf province, Saudi Arabia.沙特阿拉伯朱夫省初级保健医生对乙型肝炎病毒的知识、态度和实践
BMC Res Notes. 2014 May 9;7:288. doi: 10.1186/1756-0500-7-288.
7
HBV infection in relation to consistent condom use: a population-based study in Peru.在秘鲁进行的一项基于人群的研究显示，HBV 感染与坚持使用安全套有关。
PLoS One. 2011;6(9):e24721. doi: 10.1371/journal.pone.0024721. Epub 2011 Sep 13.
8
Post exposure prophylaxis of HIV transmission after occupational injuries in Queen Elizabeth Central Hospital, Blantyre, Malawi, 2003 - 2008.2003 - 2008年马拉维布兰太尔伊丽莎白女王中央医院职业伤害后HIV传播的暴露后预防
Malawi Med J. 2010 Mar;22(1):15-9. doi: 10.4314/mmj.v22i1.55903.
9
Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.亚洲慢性乙型肝炎 HBeAg 阳性和 HBeAg 阴性患者接受聚乙二醇干扰素 alfa-2a（40kD）联合或不联合拉米夫定治疗的持续应答。
Hepatol Int. 2008 Mar;2(1):102-10. doi: 10.1007/s12072-007-9022-5. Epub 2008 Feb 5.
10
Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India.三种不同重组乙型肝炎疫苗（基因重组乙型肝炎疫苗、安在时和重组（中国仓鼠卵巢细胞）乙型肝炎疫苗）在印度HBsAg阳性母亲所生高危婴儿中的比较
World J Gastroenterol. 2007 Jun 14;13(22):3084-9. doi: 10.3748/wjg.v13.i22.3084.

本文引用的文献

1
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.美国慢性乙型肝炎病毒感染管理的治疗算法
Clin Gastroenterol Hepatol. 2004 Feb;2(2):87-106. doi: 10.1016/s1542-3565(03)00312-4.
2
Hepatitis B virus infection--natural history and clinical consequences.乙型肝炎病毒感染——自然史与临床后果
N Engl J Med. 2004 Mar 11;350(11):1118-29. doi: 10.1056/NEJMra031087.
3
Antiretroviral therapy and HIV/hepatitis B virus coinfection.抗逆转录病毒疗法与艾滋病毒/乙型肝炎病毒合并感染
Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S98-103. doi: 10.1086/381451.
4
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.阿德福韦酯单独或与拉米夫定联合用于拉米夫定耐药的慢性乙型肝炎患者。
Gastroenterology. 2004 Jan;126(1):91-101. doi: 10.1053/j.gastro.2003.10.051.
5
Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.聚乙二醇干扰素α-2a（40 kDa）：乙肝e抗原阳性慢性乙型肝炎治疗的一项进展。
J Viral Hepat. 2003 Jul;10(4):298-305. doi: 10.1046/j.1365-2893.2003.00450.x.
6
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.慢性乙型肝炎患者肝癌筛查的甲胎蛋白和/或肝脏超声检查
Cochrane Database Syst Rev. 2003(2):CD002799. doi: 10.1002/14651858.CD002799.
7
Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment.人类免疫缺陷病毒感染患者中的乙型肝炎：流行病学、自然史及治疗
Semin Liver Dis. 2003 May;23(2):125-36. doi: 10.1055/s-2003-39951.
8
EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version).欧洲肝脏研究学会乙型肝炎国际共识会议。2002年9月13 - 14日：瑞士日内瓦。共识声明（简短版）
J Hepatol. 2003 Apr;38(4):533-40. doi: 10.1016/s0168-8278(03)00083-7.
9
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.阿德福韦酯治疗乙肝e抗原阳性慢性乙型肝炎。
N Engl J Med. 2003 Feb 27;348(9):808-16. doi: 10.1056/NEJMoa020681.
10
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.阿德福韦酯用于治疗乙肝e抗原阴性慢性乙型肝炎。
N Engl J Med. 2003 Feb 27;348(9):800-7. doi: 10.1056/NEJMoa021812.

Preventing and treating hepatitis B infection.

作者信息

Aggarwal Rakesh, Ranjan Piyush

机构信息

Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India.

出版信息

BMJ. 2004 Nov 6;329(7474):1080-6. doi: 10.1136/bmj.329.7474.1080.

DOI:10.1136/bmj.329.7474.1080
PMID:15528620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC526122/
Abstract
摘要